000 | 01315 a2200337 4500 | ||
---|---|---|---|
005 | 20250516172835.0 | ||
264 | 0 | _c20131119 | |
008 | 201311s 0 0 ger d | ||
022 | _a1439-4413 | ||
024 | 7 |
_a10.1055/s-0033-1349501 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWendtner, C-M | |
245 | 0 | 0 |
_a[Chemotherapy-free treatment of chronic lymphocytic leukemia?]. _h[electronic resource] |
260 |
_bDeutsche medizinische Wochenschrift (1946) _cOct 2013 |
||
300 |
_a2104-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aBiological Products _xtherapeutic use |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aDrugs, Investigational _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLenalidomide |
650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
650 | 0 | 4 | _aRituximab |
650 | 0 | 4 |
_aThalidomide _xanalogs & derivatives |
773 | 0 |
_tDeutsche medizinische Wochenschrift (1946) _gvol. 138 _gno. 41 _gp. 2104-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0033-1349501 _zAvailable from publisher's website |
999 |
_c23134767 _d23134767 |